Phase 1 trial of GB-7624 in atopic dermatitis
Latest Information Update: 15 Jan 2025
Price :
$35 *
At a glance
- Drugs GB 7624 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Pharmacokinetics
- 15 Jan 2025 New trial record
- 09 Jan 2025 According to Generate Biomedicines media release, company is preparing for a Phase 1 trial in early 2025, targeting atopic dermatitis.